Baird Financial Group, Inc. Bio Rad Laboratories, Inc. Transaction History

Baird Financial Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $413,656 - $523,478	1,542 Added 9.58%	17,634 $4.82 Million
Q1 2024 May 14, 2024	BUY	$304.11 - $351.99 $1.19 Million - $1.38 Million	3,921 Added 32.22%	16,092 $5.57 Million
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $457,929 - $620,568	-1,700 Reduced 12.26%	12,171 $3.93 Million
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $362,158 - $436,999	1,034 Added 8.05%	13,871 $4.97 Million
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $3.62 Million - $4.9 Million	10,077 Added 365.11%	12,837 $4.87 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $153,659 - $184,601	367 Added 15.34%	2,760 $1.32 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $51,986 - $70,970	126 Added 5.78%	2,305 $962,000
Q2 2022 Aug 08, 2022	BUY	$463.67 - $597.16 $85,315 - $109,877	184 Added 9.22%	2,179 $1.08 Million
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $106,487 - $149,290	203 Added 11.33%	1,995 $1.12 Million
Q4 2021 Feb 09, 2022	BUY	$708.84 - $794.68 $207,690 - $232,841	293 Added 19.55%	1,792 $1.35 Million
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $689,280 - $865,406	1,048 Added 232.37%	1,499 $1.12 Million
Q2 2021 Aug 11, 2021	SELL	$576.64 - $649.04 $31,138 - $35,048	-54 Reduced 10.69%	451 $291,000
Q1 2021 May 13, 2021	BUY	$547.01 - $662.35 $276,240 - $334,486	505 New	505 $289,000
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $2.27 Million - $2.66 Million	-7,099 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $2.16 Million - $2.45 Million	7,099 New	7,099 $2.36 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.46B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.